Display options
Share it on

Risk Manag Healthc Policy. 2018 Dec 03;11:243-250. doi: 10.2147/RMHP.S176517. eCollection 2018.

Is methicillin-resistant .

Risk management and healthcare policy

Aparajita Chatterjee, Shipra Rai, Vasudeva Guddattu, Chiranjay Mukhopadhyay, Kavitha Saravu

Affiliations

  1. Department of Medicine, Kasturba Medical College, Manipal Academy of Higher Education (MAHE), Manipal, Madhav Nagar, Karnataka, India, [email protected], [email protected].
  2. Department of Statistics, Prasanna School of Public Health, Manipal Academy of Higher Education (MAHE), Manipal, Madhav Nagar, Karnataka, India.
  3. Department of Microbiology, Kasturba Medical College Manipal Academy of Higher Education (MAHE), Manipal, Madhav Nagar, Karnataka, India.
  4. Manipal McGill Center for Infectious Diseases, Prasanna School of Public Health, Manipal Academy of Higher Education (MAHE), Manipal, Madhav Nagar, Karnataka, India, [email protected].

PMID: 30584380 PMCID: PMC6284536 DOI: 10.2147/RMHP.S176517

Abstract

PURPOSE: To determine morbidity and mortality of methicillin-resistant

METHODS: A cohort study among hospitalized adult patients with culture proven MRSA or MSSA monoinfection were recruited in a tertiary referral center in South India from November 2011 to December 2012.

RESULTS: Of total 551 subjects, 284 (52%) had MRSA and 267 (48%) MSSA infection. A total of 184 (65%) subjects had health care-associated MRSA (HA-MRSA) and 100 (35%) community-associated MRSA (CA-MRSA). Chronic kidney disease and recent antibiotic use had significant association with MRSA. MRSA patients had significant respiratory infection (OR 2.24 [1.04, 5.16]) and bacteremia (OR 2.24 [10.40, 5.16]), relative to MSSA. MSSA group had better survival function compared to MRSA group (

CONCLUSION: MRSA imposes a huge burden in Indian scenario and HA-MRSA remains the main culprit. Patients with history of chronic kidney disease and recent use of antibiotics were found to be at a higher risk. Patients with MRSA infections tend to have poorer outcomes in terms of longer hospital stay, greater complications, and mortality.

Keywords: India; Staphylococcus aureus; impact; methicillin-resistant Staphylococcus aureus; morbidity; mortality; outcome; prognosis; risk factors

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

References

  1. Clin Infect Dis. 2000 Feb;30(2):368-73 - PubMed
  2. Arch Intern Med. 2002 Oct 28;162(19):2229-35 - PubMed
  3. Clin Infect Dis. 2003 Jan 1;36(1):53-9 - PubMed
  4. Clin Infect Dis. 2003 Mar 1;36(5):592-8 - PubMed
  5. Infect Control Hosp Epidemiol. 1992 Oct;13(10):587-93 - PubMed
  6. Am J Infect Control. 2004 Dec;32(8):470-85 - PubMed
  7. N Engl J Med. 2006 Aug 17;355(7):666-74 - PubMed
  8. Infect Control Hosp Epidemiol. 2007 Sep;28(9):1047-53 - PubMed
  9. JAMA. 2007 Oct 17;298(15):1763-71 - PubMed
  10. Clin Infect Dis. 2008 Mar 15;46(6):799-806 - PubMed
  11. Clin Infect Dis. 2008 Mar 15;46(6):787-94 - PubMed
  12. Infect Control Hosp Epidemiol. 2008 Nov;29(11):996-1011 - PubMed
  13. J Clin Microbiol. 2009 Mar;47(3):590-5 - PubMed
  14. PLoS One. 2009 Aug 04;4(8):e6512 - PubMed
  15. Infect Control Hosp Epidemiol. 2010 Apr;31(4):365-73 - PubMed
  16. Int J Antimicrob Agents. 2010 Jul;36(1):28-32 - PubMed
  17. J Assoc Physicians India. 2010 Dec;58 Suppl:25-31 - PubMed
  18. J Assoc Physicians India. 2010 Dec;58 Suppl:37-40 - PubMed
  19. Int J Antimicrob Agents. 2011 Oct;38(4):331-5 - PubMed
  20. ISRN Dermatol. 2012;2012:248951 - PubMed
  21. PLoS One. 2013;8(1):e52722 - PubMed
  22. Indian J Med Res. 2013 Feb;137(2):363-9 - PubMed
  23. Int J Infect Dis. 2013 Nov;17(11):e1051-5 - PubMed
  24. Scientifica (Cairo). 2014;2014:479048 - PubMed
  25. J Lab Physicians. 2017 Oct-Dec;9(4):264-268 - PubMed
  26. J Lab Physicians. 2017 Oct-Dec;9(4):317-321 - PubMed
  27. J Family Med Prim Care. 2018 Jan-Feb;7(1):162-166 - PubMed

Publication Types